![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1577, 2007-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Medicaid access restrictions impact statin use
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 522, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Statin use linked with impotence
Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Post-ACS statin use suboptimal
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA recommends restrictions for piroxicam use
Reactions Weekly, Vol. 1, Iss. 1158, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
EMEA recommends restrictions for piroxicam use
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :